Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

CVS' health services division processed 484.1 million pharmacy claims during the quarter, down from 579.6 million during the ...

In September, the Federal Trade Commission took aim at big pharmacy benefits managers, including CVS subsidiary Caremark, accusing them of inflating insulin prices. “We are not surprised by the ...

CVS Health is one of three pharmacy benefit managers targeted in a lawsuit from the Federal Trade Commission, which has accused the companies of driving up the price of insulin. The three firms ...

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

and placed the burden of high insulin costs on vulnerable patients. Caremark also sits at the intersection of CVS’ retail pharmacy operation and its Aetna insurer, boosting the competitive ...

In a lawsuit filed last month against CVS Caremark and two other pharmacy benefit managers, the agency said the companies negotiated discounts on insulin but then kept the rebates for themselves ...

PORTLAND, GA, UNITED STATES, November 5, 2024 /EINPresswire / -- The global Implantable Insulin Pump Market was pegged at $2.67 billion in 2020, and is estimated to reach $6.44 billion by 2030, ...